» Articles » PMID: 32307924

Gene-disease Association Study of Tumor Necrosis Factor-α G-308A Gene Polymorphism with Risk of Major Depressive Disorder: A Systematic Review and Meta-analysis

Overview
Journal Brain Behav
Specialty Psychology
Date 2020 Apr 21
PMID 32307924
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The single nucleotide polymorphism (SNP) of the tumor necrosis factor-α (TNF-α) G-308A gene is the most studied regarding susceptibility to major depressive disorder (MDD). However, results have been controversial perhaps due to the heterogeneous genetic backgrounds influenced by race as well as subtypes of depression.

Methods And Materials: A systematic MEDLINE search was performed to retrieve all published studies that identified the connection between the TNF-α G-308A gene polymorphism and the risk of MDD.

Results: There was no statistical difference between the allele frequencies or genotypes of TNF-α G-308A gene and the depressive patients or healthy subjects in the five models tested. Further, subgroup analyses showed that the TNF-α G-308A gene polymorphism also did not confer susceptibility to poststroke, late-life, maternal, or major depression. Publication bias analysis showed p values were more than .05, suggesting that the 9 articles included in the current analysis had no publication bias.

Conclusion: Neither the allele frequencies nor genotypes of TNF-α G-308A gene could be served as an independent risk factor of depression.

Citing Articles

Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder.

Mikhalitskaya E, Vyalova N, Ermakov E, Levchuk L, Simutkin G, Bokhan N Genes (Basel). 2023; 14(7).

PMID: 37510364 PMC: 10379485. DOI: 10.3390/genes14071460.


Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio in Depression: An Updated Systematic Review and Meta-Analysis.

Cheng Y, Wang Y, Wang X, Jiang Z, Zhu L, Fang S Front Psychiatry. 2022; 13:893097.

PMID: 35782448 PMC: 9240476. DOI: 10.3389/fpsyt.2022.893097.


Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature.

Remes O, Mendes J, Templeton P Brain Sci. 2021; 11(12).

PMID: 34942936 PMC: 8699555. DOI: 10.3390/brainsci11121633.


Preliminary investigation of two promoter region polymorphisms of the gene in patients with recurrent depressive disorder.

Jelen A, Zebrowska-Nawrocka M, Szmajda-Krygier D, Mazur K, Galecki P, Balcerczak E Biomed Rep. 2021; 15(6):105.

PMID: 34760278 PMC: 8567462. DOI: 10.3892/br.2021.1481.


Secondary Mania induced by TNF-α inhibitors: A systematic review.

Miola A, Dal Porto V, Meda N, Perini G, Solmi M, Sambataro F Psychiatry Clin Neurosci. 2021; 76(1):15-21.

PMID: 34590391 PMC: 9298409. DOI: 10.1111/pcn.13302.


References
1.
Zunszain P, Hepgul N, Pariante C . Inflammation and depression. Curr Top Behav Neurosci. 2012; 14:135-51. DOI: 10.1007/7854_2012_211. View

2.
Dong C, Zhang J, Yao W, Ren Q, Yang C, Ma M . Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav. 2016; 144:7-12. DOI: 10.1016/j.pbb.2016.02.005. View

3.
Kim J, Kang H, Kim J, Bae K, Kim S, Kim J . Associations of Tumor Necrosis Factor-α and Interleukin-1β Levels and Polymorphisms with Post-Stroke Depression. Am J Geriatr Psychiatry. 2017; 25(12):1300-1308. DOI: 10.1016/j.jagp.2017.07.012. View

4.
Yao W, Zhang J, Dong C, Zhuang C, Hirota S, Inanaga K . Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav. 2015; 136:7-12. DOI: 10.1016/j.pbb.2015.06.012. View

5.
Mihailova S, Ivanova-Genova E, Lukanov T, Stoyanova V, Milanova V, Naumova E . A study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ gene polymorphisms in patients with depression. J Neuroimmunol. 2016; 293:123-128. DOI: 10.1016/j.jneuroim.2016.03.005. View